REIMBURSEMENT LANDSCAPE FOR MOLECULAR TESTING IN NON-SMALL CELL LUNG CANCER (NSCLC) IN THE UNITED STATES

被引：0
|
作者：
Nellesen, D. [1 ]
Patton, C. [1 ]
Mutebi, A. [2 ]
Culver, K. W. [2 ]
机构：
[1] Anal Grp Inc, Menlo Pk, CA USA
[2] Novartis Pharmaceut, E Hanover, NJ USA
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.04.1170
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMD97
引用
收藏
页码：S175 / S175
页数：1
相关论文
共 50 条
  • [21] Molecular characteristics of HRAS mutated non-small cell lung cancer (NSCLC)
    Trabolsi, Asaad
    Rodriguez, Estelamari
    Kareff, Samuel Alexander
    Korn, Michael
    Xiu, Joanne
    Liu, Stephen
    Walker, Philip
    Ma, Patrick
    Mamdani, Hirva
    Nieva, Jorge
    Borghaei, Hossein
    Nabhan, Chadi
    Nagasaka, Misako
    Puri, Sonam
    Lopes, Gilberto
    [J]. CANCER RESEARCH, 2022, 82 (12)
  • [22] Gemcitabine in Non-Small Cell Lung Cancer (NSCLC)
    Christian Manegold
    Petr Zatloukal
    Kurt Krejcy
    Johannes Blatter
    [J]. Investigational New Drugs, 2000, 18 : 29 - 42
  • [23] BRCAness in non-small cell lung cancer (NSCLC).
    Waqar, Saiama Naheed
    Devarakonda, Siddhartha H. K.
    Michel, Loren S.
    Maggi, Leonard B.
    Watson, Mark
    Guebert, Kalin
    Carpenter, Danielle
    Sleckman, Barry P.
    Govindan, Ramaswamy
    Morgensztern, Daniel
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [24] Eicosanoids in non-small cell lung cancer (NSCLC)
    Johnson, D. H.
    Horn, L.
    Zhao, Z.
    Milne, G.
    Morrow, J.
    Sandler, A.
    Shyr, Y.
    Carbone, D. P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [25] Gemcitabine in non-small cell lung cancer (NSCLC)
    Manegold, C
    Zatloukal, P
    Krejcy, K
    Blatter, J
    [J]. INVESTIGATIONAL NEW DRUGS, 2000, 18 (01) : 29 - 42
  • [26] The rapidly evolving landscape of biomarker testing in non-small cell lung cancer
    VanderLaan, Paul A.
    Rangachari, Deepa
    Costa, Daniel B.
    [J]. CANCER CYTOPATHOLOGY, 2021, 129 (03) : 179 - 181
  • [27] The evolving landscape of biomarker testing for non-small cell lung cancer in Europe
    Kerr, Keith M.
    Bibeau, Frederic
    Thunnissen, Erik
    Botling, Johan
    Ryska, Ales
    Wolf, Jurgen
    Ohrling, Katarina
    Burdon, Peter
    Malapelle, Umberto
    Buttner, Reinhard
    [J]. LUNG CANCER, 2021, 154 : 161 - 175
  • [28] Molecular Testing for Non-Small Cell Lung Cancer in Latin American
    Ce Coelho, J.
    Gelatti, A.
    Caorsi, F.
    Mathias, C.
    Werutsky, G.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1909 - S1909
  • [29] Strategies for Optimizing Molecular Testing in Non-Small Cell Lung Cancer
    Moore, Kathleen
    [J]. ONCOLOGY-NEW YORK, 2021, 35 (04): : 207 - 209
  • [30] Classification, Immunohistochemical and Molecular Testing of Non-Small Cell Lung Cancer
    Mak, J. K. C.
    Cain, O.
    Hero, I.
    [J]. JOURNAL OF PATHOLOGY, 2017, 241 : S13 - S13
12345